Atrian Medical Ltd.
  • Home
  • Technology
  • Our Team
  • Publications
  • News
  • Contact
Select Page

Atrian completes enrollment of second clinical study

Pioneering cardiac autonomic pulsed field ablation (PFA) technology provides a unique option for enhancing the durability of AF ablation.
Read More

Recent Posts

  • Novel Percutaneous Epicardial Autonomic Modulation in the Canine for Atrial Fibrillation: Results of an Efficacy and Safety Study
  • Electroporation of epicardial autonomic ganglia: Safety and efficacy in medium‐term canine models
  • Open-chest Pulsed Electric Field Ablation of Cardiac Ganglionated Plexi in Acute Canine Models
  • Safety and Feasibility of Epicardial Percutaneous Access and Maneuverability With a Novel Ablation Catheter for the Treatment of Atrial Fibrillation in a Porcine Model
  • Establishing Irreversible Electroporation Electric Field Potential Threshold in A Suspension In Vitro Model for Cardiac and Neuronal Cells

Recent Comments

  • A WordPress Commenter on Medtech Innovator Accelerator
© 2021 ATRIAN MEDICAL LTD. ALL RIGHTS RESERVED.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

Cookie Policy

More information about our Cookie Policy